The EGFR is widely expressed by a range of tumours, including CRC [16-18] where it has been reported to be associated with a slightly poorer prognosis.[19,20] Cetuximab blockade of EGFR results in inhibition of tumour growth, invasion, metastasis and angiogenesis. The gene discussed is EGFR; the disease is neoplasm.